Please login to the form below
Michael J Fox Foundation
This page shows the latest Michael J Fox Foundation news and features for those working in and with pharma, biotech and healthcare.
Novartis bolsters anti-inflammatory R&D with $1.6bn IFM Tre buy
Last month, Inflazome won a $1m grant from the Michael J. ... Fox Foundation (MJFF) for an imaging approach that will be used to develop NLRP3 drugs for Parkinson’s and other neurodegenerative diseases.
Latest news
-
Pfizer joins up with IBM for internet-of-things collaboration
Wearables have piqued the industry's interest in Parkinson's, with UCB beginning trials of a wearable sensor in December, the Michael J Fox Foundation backing a different trial earlier this
-
Michael J Fox Foundation backs wearable device trial
Trials of a new therapy for Parkinson's disease developed by Cynapsus Therapeutics will use a smartwatch-like device to monitor results, thanks to backing from the Michael J Fox Foundation. ... All the participants in Fox Insight receive a free Pebble
-
UCB trials wearable sensor for Parkinson's
Earlier this year the Michael J Fox Foundation, which funded the first web-based system to remotely access data from 'miniature sensors attached to the body' in 2008, tied up with ... The Michael J Fox Foundation also collaborated with biotech Sage
-
Another $2m donated to further neurodegenerative commitment
Fox Foundation for Parkinson's Research in the US, the Weston Brain Institute in Canada and Alzheimer's Research UK, which joins as the programme makes a second round of research ... Fox Foundation, added: “A collaboration such as BAND promotes
-
Charity coalition pledges millions for brain disease research
Neuro–MAP's partners are Alzheimer's Association US, Alzheimer Research UK, Alzheimer's Society UK, ALS Association, Michael J Fox Foundation, MND Association, MRC Technology, Northern Health Science Alliance and
More from news
Approximately 2 fully matching, plus 10 partially matching documents found.
Latest Intelligence
-
Pfizer and IBM's tech-enabled 'Parkinson’s house'
Parkinson’s will continue to confound healthcare professionals for a long time yet and a cure remains distant but Rachel Dolhun, a movement disorder specialist with the Michael J Fox Foundation,
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- Regeneron launches phase 3 COVID-19 antibody trial in the UK
- 20 for 2020 – Five pharma companies to watch
- FDA approves Roche’s Actemra COVID-19 trial
- Moderna inks R&D agreements with Vertex and Chiesi
- OPEN Health’s Digital team have won a Bronze Award at the PM Society Digital Awards 2020
- New restrictions announced as UK’s COVID-19 alert level is increased
- Keytruda plus chemotherapy cuts risk of death by 27% in advanced oesophageal cancer
- AZ/Merck's Lynparza improves survival in certain prostate cancers
- The flexible salesforce
- Navigating engagement and remote working during the pandemic
PMHub
Videum Health
Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...
Latest intelligence
- Improve clinical trials through patient journey mapping
- Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
- Alone we can do so little, together we can do so much
- Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
Quick links
Infographics
